Table 4.

ADR survey: prevalence of HIV DR by drug class

	Maputo (N = 5)			Tete (N = 8)
Characteristic	N	%	95% CI	N	%
VL from 500–999 copies/mL
NRTI DR	2	40	5.2–85.0	6	75.0
NNRTI DR	2	40	5.2–85.0	8	100
NRTI and NNRTI DR	2	40	5.2–85.0	8	100
PI DR	0	0	0.0–50.0	0	0
No DR	3	60.0	14.6–94.7	0	0
Failed DRT amplification	2	40.0		1	12.5
VL ≥ 1000 copies/mL	Maputo (N = 53)			Tete (N = 72)
Any HIVDR	43	81.1	68.0–90.5	69	95.8
NRTI DR	37	69.8	55.6–81.6	55	76.4
NNRTI DR	43	81.1	68.0–90.5	69	95.8
NRTI and NNRTI DR	35	66.0	51.7–78.4	55	76.4
PI DR	0	0	0.0–6.0	0	0
No DR	10	18.9	9.4–31.2	3	4.2